Publicaciones en colaboración con investigadores/as de Hospital del Mar (25)

2024

  1. GEDEFO-SEFH management of antineoplastic extravasations survey results

    Journal of Oncology Pharmacy Practice, Vol. 30, Núm. 1, pp. 67-77

2022

  1. Adequacy of the use of antibiotic prophylaxis in urinary tract infection in primary care of the Alto Deba Integrated Health Organization

    Atencion Primaria Practica, Vol. 4, Núm. 1

2021

  1. Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

    Scientific reports, Vol. 11, Núm. 1, pp. 5375

  2. Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 198-203

  3. Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer

    Clinical Nutrition, Vol. 40, Núm. 4, pp. 1537-1545

  4. Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study)

    International Journal of Cancer, Vol. 148, Núm. 6, pp. 1360-1371

  5. Fosfomycin: Salt is what really matters

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 4, pp. 206-207

  6. Occupational heat exposure and breast cancer risk in the MCC-Spain study

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 2, pp. 364-372

  7. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

    Scientific Reports, Vol. 11, Núm. 1

  8. Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain)

    PLoS ONE, Vol. 16, Núm. 5 May

2020

  1. Association between polyphenol intake and breast cancer risk by menopausal and hormone receptor status

    Nutrients, Vol. 12, Núm. 4

  2. Quality of life in a cohort of 1078 women diagnosed with breast cancer in spain: 7-year follow-up results in the mcc-spain study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 22, pp. 1-16

2019

  1. Dietary inflammatory index, dietary non-enzymatic antioxidant capacity, and colorectal and breast cancer risk (MCC-Spain study)

    Nutrients, Vol. 11, Núm. 6

2018

  1. Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period

    Saudi Pharmaceutical Journal, Vol. 26, Núm. 5, pp. 703-708

2017

  1. Computerized pharmacy surveillance and alert system for drug-related problems

    Journal of Clinical Pharmacy and Therapeutics, Vol. 42, Núm. 2, pp. 201-208

  2. Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections

    Drug Design, Development and Therapy, Vol. 11, pp. 65-82

2014

  1. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety, Vol. 23, Núm. 9, pp. 923-932

  2. Patient risk factors for developing a drug-related problem in a cardiology ward

    Therapeutics and Clinical Risk Management, Vol. 11, pp. 9-15

2013

  1. Normalization of creatine kinase values in a case of rhabdomyolysis during daptomycin treatment

    Indian Journal of Pharmacology, Vol. 45, Núm. 2, pp. 193-194

  2. Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

    Drug Design, Development and Therapy, Vol. 7, pp. 243-265